Colorectal Oncogenesis and Inflammation in a Rat Model Based on Chronic Inflammation due to Cycling DSS Treatments by Håkansson, Åsa et al.
Hindawi Publishing Corporation
Gastroenterology Research and Practice
Volume 2011, Article ID 924045, 15 pages
doi:10.1155/2011/924045
Research Article
Colorectal Oncogenesisand Inﬂammation in a Rat Model Based
on Chronic Inﬂammation due to Cycling DSS Treatments
˚ Asa H˚ akansson,1 CamillaBr¨ anning,2 G¨ oranMolin,1 DiyaAdawi,3 Marie-LouiseHagsl¨ att,1
MargaretaNyman,2 Bengt Jeppsson,3 andSivAhrn´ e1
1Food Hygiene, Division of Applied Nutrition and Food Chemistry, Lund University, 221 00 Lund, Sweden
2Division of Applied Nutrition and Food Chemistry, Lund University, 221 00 Lund, Sweden
3Department of Surgery, Sk˚ ane University Hospital, Lund University, 205 02 Malm¨ o, Sweden
Correspondence should be addressed to ˚ Asa H˚ akansson, asa.hakansson@appliednutrition.lth.se
Received 18 February 2011; Accepted 2 August 2011
Academic Editor: Genevieve B. Melton-Meaux
Copyright © 2011 ˚ Asa H˚ akansson et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Inﬂammation is known to be linked with development of colorectal cancer, and the aim was to assess the malignant potential and
degreeofinﬂammationinadextran-sulphate-sodium-(DSS-)inducedcycliccolonictumourmodel(CTM)inratsandtocompare
it with the azoxymethane-(AOM-) induced CTM model. Tumours developed in both groups, although, in the DSS group, the
colonic mucosa appeared edematous and the number of haemorrhagic erosions and quantity of dysplastic lesions were higher
as well as the mucosal concentration of myeloperoxidase and faecal viable count of Enterobacteriaceae. The livers were aﬀected
as evaluated by steatosis, parenchymal loss, haemorrhage, and inﬂammatory inﬁltrations, and higher proportions of acetate and
lower proportions of butyrate in colonic content were found. The DSS model seems to mimic the clinical situation and may be
valuable for investigation of inﬂammation-related dysplasia and colon cancer, as well as for altered liver function by endogenous
inﬂammatory mediators.
1.Introduction
Chronic inﬂammation is characterised by a continued active
inﬂammatory response and tissue destruction, and it seems
to be a driving mechanism for promoting the development
of carcinoma in colon and rectum of patients suﬀering
from ulcerative colitis (UC), one of the major forms of the
idiopathic inﬂammatory bowel diseases [1]. Compared to
thegeneralpopulation,long-termUCpatientshavehighrisk
of developing colorectal cancer, which increases as the extent
and duration of the disease increase [2].
Mucosal inﬂammation may lead to colonic carcino-
genesis through diﬀerent mechanisms, such as induction
of genetic mutations, increased cryptal cell proliferation,
changes in crypt cell metabolism and bile-acid enterohepatic
circulation, and alterations in bacterial ﬂora [3, 4]. Dysplasia
describes architectural and cytological abnormalities in the
epithelium that predispose an organ to cancer develop-
ment, and dysplasia has been indicated as an indicator of
malignancy in UC [5]. The colonic epithelium provides
acriticalbarriertoprotectthehostfromresidentcommensal
and pathogenic microbes. Inﬂammation within thegastroin-
testinal tract profoundly inﬂuences mucosal integrity and
its ability to resist injury induced by luminal factors. In
patients with adenocarcinoma of the large bowel, disruption
of the intestinal barrier is assumed, and ﬁndings suggest
that intestinal bacteria translocate from the bowel in large
numbers [6].
The microbiota of the distal ileum and colon are com-
plex, metabolically active and interact with intestinal epithe-
lial and immune cells. Compositional changes in the
intestinal microbiota can lead to decreased protective and
increased quantities of aggressive bacterial species, and
more proinﬂammatory faecal microbial communities have
been observed in patients with UC compared with healthy
individuals [7]. Lipopolysaccharide (LPS), derived from the
outer envelope of Gram-negative bacteria that are physio-
logically part of the gut microbiota, is a major inducer of
the inﬂammatory response and causes extensive damage to
a variety of organs, including the liver [8], during increased2 Gastroenterology Research and Practice
intestinal permeability and bacterial translocation. A poten-
tial link between bacterial components and hepatobiliary
inﬂammationhasbeensubstantiated[9],andawiderangeof
hepatic histological abnormalities has been found in patients
with chronic UC [10], with fatty inﬁltration of hepatocytes
and primary sclerosing cholangitis being the most common
lesions [11].
Short-chain fatty acids (SCFAs), produced in the colon
during anaerobic fermentation by the microﬂora, represent
a major constituent of the luminal contents. The three major
SCFAs formed during fermentation are acetate, propionate,
and butyrate, among which butyrate and propionate most
eﬃciently ameliorate an ongoing inﬂammatory response
[12].
Mechanisms of colon carcinogenesis have been eluci-
dated using several animal models, the majority using azoxy-
methane (AOM) or other carcinogenic agents alone or in
combination with dextran sulphate sodium (DSS). DSS is
a nongenotoxic sulphated polysaccharide used to induce
experimental chronic colitis and colitis-associated neoplasia,
histopathologically reminiscent of human UC [13], but
the precise mechanisms by which DSS induces colonic in-
ﬂammation are still unknown. As observed in humans, dys-
plasia and/or cancer develop as ﬂat lesions or as dysplasia-
associated lesions during long-term DSS administration
[14]. AOM is a colon-speciﬁc carcinogen that serves as
an eﬀective tool for assessing colon tumours in suscep-
tible rodents [15]. Administration of AOM is an extremely
eﬃcient method of inducing adenocarcinoma in the colon.
However, whether or not this model represents inﬂam-
mation-driven carcinogenesis can be questioned.
It is therefore of interest to gain insight into the relation-
ship between colonic inﬂammation and carcinogenesis in a
model with prolonged inﬂammatory stress. In the present
study, we have focused on histopathological evaluation of
colon and liver specimens, Enterobacteriaceae versus lacto-
bacilli, SCFAs, and inﬂammatory markers.
2.MaterialsandMethods
2.1. Animals and Experimental Design. Female Sprague-
DawleyratswereobtainedfromM¨ olleg˚ ard(Viby,Denmark),
and they were housed four per cage in plastic-bottomed
cages. Animals were allowed free access to water, while feed
intake was restricted to 23g (dwb, dry weight basis) per
rat and day. Lighting was controlled on a 12-h light-dark
cycle and temperature maintained at 22◦C. All procedures
involving animals and their care were approved by the Ethics
Committee for Animal Studies at Lund University. Rats
were divided into three groups: untreated animals, that is,
the normal control (NC group), animals treated in cycles
with dextran sulphate sodium (DSS group), and animals
treated with azoxymethane (AOM group). The DSS group
was administered 4% (w/v) DSS (MW = 36,000–50,000; ICN
Biomedicals Inc., Aurora, Ohio) dissolved in drinking water
for7days,followedby10daysoftapwater,andthiscyclewas
then repeated 11 times.
The DSS solution was changed daily. The AOM group
was given a single intraperitoneal injection (15mg/kg body-
Table 1: Diet composition. Composition of test diets (g/kg dwb)
given to rats in all groups (NC, DSS, and AOM).
Component
Oat bran 2911
Casein 160
DL-methionine 1.2
Maize oil 50
Mineral mixture2 48
Vitamin mixture3 8
Choline chloride 2
Sucrose 100
Wheat starch4 380
1Corresponding to 50g dietary ﬁbre/kg diet (dwb).
2Containing (g kg−1)0 . 5 5C u S O 4· H2O, 2.0 ZnSO4· 7H2O, 498 KH2PO4,
258 NaH2PO4· 2H2O, 487 CaCO3, 0.1 KI, 86 MgSO4,1 2F e S O 4· 7H2O, 5
MnSO4· H2O, 0.03 CoCl · 6H2O, 153 NaCl, 0.02 CrCl3· 6H2O, 0.02 Na2Se.
3Containing (gkg−1) 0.62 menadion, 2.5 thiamin hydrochloride, 2.5
riboﬂavin, 1.25 pyridoxin hydrochloride, 6.25 calcium pantothenate, 6.25
nicotinic acid, 0.25 folic acid, 12.5 inositol, 1.25 p-aminobenzoic acid, 0.05
biotin, 0.00375 cyanocobalamin, 0.187 retinol palmitate, 0.00613 calciferol,
25 d-α- tocopheryl acetate, and 941.25 maize starch.
4Wheat starch (Cerestar, Krefeld, Germany).
weight) of AOM (Sigma, St. Louis, USA, dissolved in 0.9%
NaCl), and starting 1 week after the injection, animals were
administered 5% DSS in drinking water for 7 days, after
which the rats were monitored without further treatment for
18 weeks. All chemicals were of analytical grade.
Throughout the study, the diet to all rats included oat
bran at a level of 50g dietary ﬁbre/kg (dwb) (Table 1). The
dry matter content was adjusted with wheat starch, and
the content of dietary ﬁbre was 17.2g/100g (dwb), where
1.6g/100g (dwb) was Klason lignin, that is, components
not soluble in 12M H2SO4. The nonstarch polysaccharides
consisted mainly of glucose (61%), xylose (19%), and
arabinose(12%)(datanotshown).After7daysofadaptation
to the diet, the experimental period started and feed residues
were collected daily.
Ratswereweighedbeforeandaftertheadaptationperiod,
as well as daily during the DSS consumption. An attempt
was made to quantify the amount of drinking water and DSS
load ingested by the rats. Drinking volumes were recorded
every 24h for each cage (four animals), and the DSS load
per animal was calculated over the experimental period as:
(total drinking water (mL) × (DSS (g)/100 mL))/number of
animals.
2.2. Sampling. Blood samples for analysing haptoglobin and
SCFAs were taken from the saphenous vein at the beginning
of the study for all groups, during cycle 1, 5, and 10 for the
DSS group and for the AOM and NC groups, at the same
sampling times as for the DSS group. During each DSS cycle,
samplesweretakenontheseventhdayofDSSadministration
and on the tenth day of the following water period. At the
same time, faecal samples were collected for viable count and
body temperature was measured.
At the end of the experiment, the animals were anaes-
thetised with Hypnorm (Division of Janssen-Cilag Ltd.,Gastroenterology Research and Practice 3
Janssen Pharmaceutica, Beerse, Belgium), Dormicum (F.
Hoﬀman-La Roche AG, Basel, Switzerland), and water
(1:1:2) at a dose of 0.15mL/100g of body weight by a
subcutaneous injection. For analysis of cytokines and SCFAs,
arterial blood was collected and the mesenteric lymph nodes
and liver were obtained for bacterial translocation and
liver histology. The entire colorectum from the colocaecal
junction to the anal verge was excised, the luminal content
of caecum and colon was gently removed for analysis of
SCFAs, and pH was measured in caecal content before
storage at −40◦C. The large bowel was macroscopically ex-
amined for gross lesions all of which recorded, and then
the colon was cut and ﬁxed in 10% buﬀered formalin, for
24 hr. Histological examination was performed on paraﬃn-
embedded sections, after haematoxylin and eosin (H&E)
staining. Tissue samples from distal colon were also stored
for analysis of myeloperoxidase (MPO).
2.3. Clinical Scoring of Colitis. DSS-induced disease severity
was analysed in terms of disease activity index (DAI), which
in turn was calculated on the basis of weight loss, stool
consistency, andrectal bleeding. The scoring systemhas been
validated [16] and shown to correlate histologically with
pathological ﬁndings [13]. The DAI was assessed daily from
day 0 to day 7 and scored on a scale of 0–4 for each clinical
parameter and then averaged for each animal. Weight-loss,
stool, and bleeding scores were deﬁned by modiﬁed scoring
limits [17].
2.4. Myeloperoxidase (MPO) Activity. Specimens of distal
colon were collected for measurement of myeloperoxidase
(MPO) and weighed prior to storage at −70◦C until time
of assay. The assay procedure was done in accordance with
Osman et al. [18]. The activity was expressed as units per
gram of wet weight of the tissue.
2.5. Histological Evaluation. Specimens from the distal part
of colon and liver were evaluated by light microscopy.
Evaluation of macroscopic abnormalities through the entire
length of colon and microscopic alterations was evaluated
by an experienced surgeon and pathologist, respectively.
The biopsy sites of the distal colon, taken at chosen
sampling sites (polyps or dysplastic lesions and surrounding
mucosa), and the left lobe of the liver were each ﬁxed in
neutral buﬀered formalin, followed by standard procedure
for paraﬃn embedding. Serial sections were cut for each
organ and stained with haematoxylin-eosin staining. The
histological images are chosen to show diﬀerent ﬁndings in
the diﬀerent groups and do not illustrate the condition of
the complete biopsy. In the colon, the degree of dysplasia was
scored from normal mucosa to mucosa with mild dysplasia
(with distorted crypts of abnormal length and orientation)
and severe dysplasia (with severe crypt distortion, atypical
epithelial cells, reduction or loss of goblet cells, hyperchro-
matic cell nuclei, and increased numbers of cell mitoses).
A numerical scoring system was applied to enable statistical
evaluation (1 = normal mucosa; 2 = low grade dysplasia; 3 =
high grade dysplasia).
Liver specimens were evaluated for the degree of steatosis
according to Brunt et al. [19], where steatosis was scored as
absent (= 0), mild when present in <1/3 of the hepatocytes
(= 1), moderate when present in 1/3-2/3 of the hepatocytes
(= 2), and severe when present in >2/3 of the hepatocytes
(= 3). The presence and location of inﬁltrating inﬂammatory
cells and liver injury were also recorded. Degree of inﬂam-
mation in steatotic and nonsteatotic areas, stasis, and loss of
parenchyma were graded using a semiquantitative scale of 0
(absent), 1 (mild), 2 (moderate), and 3 (extensive) [20].
2.6. Bacterial Translocation. To measure bacterial translo-
cation across the intestinal epithelium, samples from the
caudate lobe of the liver and mesenteric lymph nodes
were collected aseptically and frozen immediately at −70◦C
until determination. After thawing, samples were placed
in an ultrasonic bath (Millipore, Sundbyberg, Sweden) for
5min and swirled on a Chiltern for 2min. Viable counts
were obtained from Violet-Red Bile Glucose (VRBG) agar
(Oxoid) that was incubated aerobically at 37◦Cf o r2 4 h
(Enterobacteriaceae count), Brain Heart Infusion (BHI) agar
(Difco, Detroit, Mich) that was incubated aerobically and
under anaerobic condition, as described above, at 37◦Cf o r
72h (aerobic and anaerobic bacterial count, resp.), and from
Rogosa agar (Oxoid), incubated anaerobically at 37◦Cf o r
72h(lactobacillicount).Resultswereexpressedasincidences
of positive cultures/group.
Colonies were randomly picked from the plates with
positive cultures, and the isolates were subcultured before
subjected to 16S rDNA sequencing.
2.7. Viable Count of Enterobacteriaceae and Lactobacilli in
Faeces. Faecal samples were thawed and homogenised in
the freezing medium, diluted, and plated on Rogosa agar
for lactobacilli count (Oxoid; incubated anaerobically (Gas
Pack System, Gas Pack; Becton Dickenson Microbiology
Systems, Cockeysville, Md) at 37◦Cf o r7 2 h )a n dV R B G
for Enterobacteriaceae count (Oxoid; incubated aerobically at
37◦C for 24h).
Colonies were randomly picked from countable Rogosa
agar plates (10–150 colonies). Altogether, 44 isolates were
collected.
2.8. Randomly Ampliﬁed Polymorphic DNA (RAPD) Analysis.
As template for the polymerase chain reaction, crude cell
extract was prepared in accordance with the protocol of
Quednau et al. [21] and one microlitre of PCR template
was used in the polymerase chain reaction (PCR) [21].
Agarose gel (Type III, High EEO, Sigma) electrophoresis was
run, and the gels were stained with ethidium bromide and
photographed under UV illumination.
2.9. 16S rDNA Sequencing. The primers used for ampliﬁ-
cation of the 16S rRNA genes were ENV1 (5 -AGA GTT
TGA TII TGG CTC AG-3 , Escherichia coli numbering 8–
27) and ENV2 (5 -CGG ITA CCT TGT TAC GAC TT-3 , E.
coli numbering 1511–1492) [22]. The PCR reaction mixture
contained 0.2μMo fb o t hp r i m e r s ,5 μLo ft e m p l a t eD N A ,4 Gastroenterology Research and Practice
5μL of 10x PCR reaction buﬀer with 1.5mM MgCl2 (Roche
Diagnostics GmbH, Mannheim, Germany), 200μMo fe a c h
deoxyribonucleotide triphosphate, and 2.5U of Taq DNA
polymerase (Roche Diagnostics, Mannheim, Germany) in
aﬁ n a lv o l u m eo f5 0 μL. PCR was performed in a PCR
Mastercycle 5333 (Eppendorf) with the following proﬁle: 1
cycleat94◦Cfor3min,followedby30cyclesof96◦Cfor15s,
50◦C for 30s, and 72◦C for 90s, with an additional extension
at 72◦Cf o r1 0 m i n .P C Rp r o d u c t s( 5 μL) were veriﬁed on
1.5% (wt./vol.) agarose gel in 1x TBE buﬀer (89mM Tris,
89mM boric acid, 2.5mM EDTA, pH 8.3), after ethidium
bromide staining. Amplicons were single strand sequenced
by MWG (Biotech, Ebersberg, Germany), and the 16S rDNA
sequences (mostly around 500bp) were subjected to BLAST
search against GenBank [23] or aligned to 16S rDNA
encoding sequences retrieved from the Ribosomal Data Base
(RDP-II) [24] for an approximate phylogenetic aﬃliation.
2.10. Dietary Fibre. The soluble and insoluble dietary ﬁbres
in oats were determined by a gravimetric method [25]. The
composition of the ﬁbre residues was analysed by gas-liquid
chromatography (GLC) for the neutral sugars as their alditol
acetates and spectrophotometrically for the uronic acids
[26].
2.11. Short-Chain Fatty Acids (SCFAs). The SCFAs (acetic,
propionic, isobutyric, butyric, isovaleric, and valeric acids)
were analysed in serum using GLC [27] with small modi-
ﬁcations. Water and 2-ethylbutyric acid (internal standard)
were added to the serum samples, and the SCFAs were
protonised with hydrochloric acid. To enrich the SCFAs, a
hollow ﬁbre was immersed in the serum solution and the
SCFAs were extracted into the lumen of the ﬁbre. After 16h
of extraction, the lumen content was ﬂushed and mixed
with hydrochloric acid before being injected onto a fused-
silica capillary column (DB-FFAP 125-3237, J&W Scientiﬁc,
AgilentTechnologiesInc.,Folsom,Calif,USA).ChemStation
software (Agilent Technologies Inc., Wilmington, Del, USA)
was used for the analysis GC.
The caecal and colonic amounts of SCFAs (acetic,
propionic, isobutyric, butyric, isovaleric, valeric, caproic,
and heptanoic acids) were analysed by a GLC method [28]
with minor modiﬁcations. Water mixed with hydrochloric
and 2-ethylbutyric acids were added to the faecal samples.
The suspensions were homogenised with an Ultra Turrax
T25 basic (IKA-WERKE, Staufen, Germany) and then
centrifuged (MSE Super Minor, Hugo Tillquist AB, Solna,
Sweden)beforeinjectionontoafused-silicacapillarycolumn
(see earlier).
2.12. Body Temperature. Body temperature of each rat was
measured with a rectal digital thermometer at baseline and
after the administrations of DSS and the subsequent water
period at cycle 1, 5, and 10 and during corresponding points
in time for NC and AOM groups. The rats were placed in a
restrainingdevicewhenthebodytemperaturewasmeasured.
2.13. Haptoglobin. The concentration of serum haptoglobin
was analysed using a manual microplate (96 microwell
Table 2:Histologicalevaluation.Histologicalevaluationsofcolonic
samples.Numberofanimalsshowingthehistopathologiclesionper
totalnumber analysed samplesin thegroupandan index calculated
on the basis of the scoring system.
Low-grade dysplasia High-grade dysplasia Index
NC 0/8 0/8 1.0
DSS 4/8∗ 1/8 1,75
AOM 0/7 3/7 1.86
∗Denotes P< 0.05 compared to the NC and AOM group.
plates, Nunc, Roskilde, Denmark) method. Serum was
incubated with haemoglobin (Hb) (0.12mg/mL bovine
haemoglobin (Sigma Aldrich, St Louis, USA) in 0.15M
NaCl (Merck Schuchardt, Hohenbrunn, Germany)) lead-
ing to preserved peroxidase activity of the complex. By
addition of a peroxidase substrate (chromogenic solution;
0.5M citrate buﬀer pH 3.8 (0.5M sodium citrate dihydrate
(J.T Baker B.V., Deventer, Holland), 0.5M citric acid-1-
hydrate (Merck)), 1% Tween 20 (Merck), 20mM phenol
(International Biotechnologies Inc., Eastman Kodak Co.
Rochester, NY), 0.39mM dithioerythritol (Sigma), 1.6mM
4-aminoantipyrine (Sigma), 1mM 8-anilino-1-naphthalene
sulphonic acid (Sigma), and 1μL 30% H2O2/0.7mL solution
(Merck)), the activity, which is directly proportional to the
amount of haptoglobin in the samples, was measured at
600nm(SpectraMaxM2Multi-detectionMicroplateReader,
Molecular Devices, Sunnyvale, Calif, USA) and compared
with a haptoglobin standard (2mg/mL) (Tridelta Develop-
ment Ltd., Maynooth County Kildare, Ireland).
2.14. Multiple Cytokine Assays. For quantitative analysis of
cytokines (interleukin-(IL-) 1β, IL-4, IL-6, IL-10, IL-12, IL-
17, IL-18, TNF-α,I F N - γ) and leptin, Milliplex microbeads
array system was used following the manufacturer’s recom-
mended protocols. All samples were run in duplicates, and
the results were evaluated by use of MilliplexTM Analyst v.
3.4 (Millipore). Values just below the standard curves were
set at the value of detection limit.
2.15. Statistics. Body weight change, DAI scores, MPO activ-
ity, number of dysplastic lesions, number of ulcers, scoring
used for histopathologic evaluation of colonic and liver sam-
ples, lactobacilli and Enterobacteriaceae counts, haptoglobin,
cytokines, and leptin (Figures 1, 9,a n d10 and Tables 2 and
3) were presented as medians with 25 and 75 percentiles.
The statistics were conducted in SigmaStat version 3.0 (SPSS
Inc., Chicago, Ill, USA). Diﬀerences between all groups
were evaluated by Kruskal-Wallis test one-way ANOVA on
ranks followed by all pairwise multiple comparison pro-
cedures (Student-Newman-Keuls method) if appropriate.
The diﬀerences between treatment groups were assessed by
a Mann-Whitney rank sum test. The correlation between
expectations of beneﬁt was ascertained using Pearson’s cor-
relation coeﬃcient. Calculation of the incidence of steatosis,
inﬂammatorycellinﬁltration,stasis,lossofparenchyma,and
translocation (Table 3) was conducted in QuickStat version
2.6 and was evaluated by the Fisher exact test.Gastroenterology Research and Practice 5
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Figure 1: Myeloperoxidase activities (U/g tissue) in colonic tissue;
∗denotes P<0.05 compared to the DSS group.
SCFAs were calculated as the concentrations of each acid
(μmol/g) multiplied by the caecal amount. The proportion
of individual SCFAs was calculated as a percentage of total
SCFAs for each rat before statistical evaluation (Table 5).
Feed intake, caecal content, caecal tissue weight, caecal pH,
a n dS C F A sw e r ep r e s e n t e da sm e a n s± SEM (standard error
of the mean). For statistical evaluation of the diﬀerences
between samples, one-way ANOVA using the general linear
model procedure (GLM, ANOVA) was used (Table 5). The
Minitab statistical software (Release 14) was used to make
these evaluations. Levels of signiﬁcance were tested at P<
0.05 unless stated otherwise.
3. Results
3.1. Feed Intake and Body Weight Change. At the start of
the specialised regimens, there was a body weight diﬀerence
between the groups, with a slightly higher bodyweight in the
AOM group (209 (204.5–210.8)g/animal) compared with
the DSS group (189.5 (181.5–191.0)g/animal) and the NC
(189 (187.0–192.0)g/animal) group (P<0.001).
During the study, the feed intake in the NC group
(20.1g/(d and rat)) and the DSS group (19.2g/(d and rat))
was similar, while the intake in the AOM group was some-
what lower (17.1g/(d and rat)). All animals gained weight
during the study, and, at the end, the body weight change
in the NC group (240.5 (218.5–265.5)g/animal) was higher
than in DSS (173.5 (167.0–217.5)g/animal, P = 0.015) or
AOM (159.0 (152.3–178.0)g/animal), P<0.001) groups.
Whenfeedconsumptionwastakenintoaccount,asigniﬁcant
body weight change (g/kg feed/animal) was found between
the NC (72.9 (66.2–80.5) and the AOM group (56.8 (54.4–
63.6) (P = 0.014)) but not compared to the DSS group (56.0
(53.9–70.2)). No diﬀerences in caecal content or caecal tissue
weight were found between the groups (data not shown).
3.2. Disease Activity Index. The disease activity index (DAI)
after the ﬁrst DSS cycle of the DSS group (4% DSS; 0.33
(0.33–0.5)) did not signiﬁcantly diﬀer from the DAI of
the AOM group after the singular treatment with 5% DSS
Figure 2: Normal crypt architecture and absence of inﬂammation
seen in colonic mucosa from a rat in the NC group.
(0.67 (0.33–0.67)). Many animals had soft stools and were
haemoccult positive, but their body weight gains were not
decreased during this period of treatment. Thereafter, only
mild clinical symptoms (slight rectal bleeding and soft stool)
were occasionally noted in the AOM group. In the DSS
group, the signs of colitis gradually disappeared during the
pure water period after the 1st cycle. During the second
cycle, the DAI score reached signiﬁcant diﬀerence (1.33
(0.67–1.67) P = 0.01) and over time the score gradually
increased and did not revert between the cycles of DSS
administration. At the end of the experimental period, all
animals in the DSS group exhibited rectal bleeding, loose
stool, and body weight loss at the end of DSS cycles and
a signiﬁcant higher DAI score was observed between the
ﬁrst and eleventh cycle of DSS administration (2.0 (1.5–2.3)
P<0.001). The mortality rate was 0%.
3.3. Myeloperoxidase Activity. Myeloperoxidase activity
which was used to quantify neutrophil accumulation in
colonic tissues was signiﬁcantly (P<0.05) higher in the DSS
group (14.1U/g (8.8–20.9)) than in the NC group (5.6U/g
(3.0–5.8)) and in the AOM group (5.5U/g (4.9–8.7))
(Figure 1).
3.4. Histological and Macroscopic Alterations of Colon. The
mucosal architecture of the NC group was assessed to be
normal. There was no ulceration of the epithelial lining, and
the crypts and the lamina propria inﬂammatory inﬁltrate
were normal (Figure 2).
In light microscope, the DSS group showed colonic
inﬂammation mostly conﬁned to the mucosa and sub-
mucosa, with loss of surface epithelium, inﬂammatory
cell inﬁltrations, loss of goblet cells, crypt distortion and
abscesses, mucosal ulceration and erosion, and accompany-
ing submucosal edema. The diseased condition seemed to
be distributed throughout the colon but was particularly
prominent on the left side of the large intestine and trans-
versecolon.Regenerativeandhyperplasticepithelium,which
morphologically mostly resembled low-grade dysplasia with
some sections of high-grade dysplasia and polyps diagnosedGastroenterology Research and Practice 7
Figure 3: Flat dysplasia seen in colonic mucosa from a rat in the
DSS group.
Figure 4: Dysplastic lesion in chronic inﬂamed colonic mucosa
from a rat in the DSS group.
as adenocarcinomas, was observed (Figures 3 and 4). The
incidence of low-grade dysplasia was signiﬁcantly higher
in the DSS group than in the NC group and the AOM
group (Table 2, P<0.05). In the AOM group, several
features of high-grade dysplasia was found with occasional
pedunculated adenocarcinomas showing ﬁbrovascular stalks
and heads containing abundant dysplastic epithelial glands
(Figure 5), but compared to the other groups, the diﬀerence
was not signiﬁcant. In contrast to the DSS group, the polyps
in the AOM group were segregated by minimal inﬂamma-
tion, erosion, or hyperplastic epithelium, indicating that the
disease process was not continuous (Figure 6). Examination
of speciﬁc histologic scores showed no signiﬁcant diﬀerence
(Table 2).
Morphological examination of colon from each animal
revealedvisiblethickeningofthecolonwallintheDSSgroup
(Figure 7). Invaginations as a cause of polyps (Figure 8)
and dilated descending colon were occasionally seen in
both the DSS group and the AOM group. There was no
sign of gross mucosal ulceration or thickening of the colon
wall in the AOM group. Quantitatively, the number of
lesions classiﬁed as low-grade dysplasia (3.0 (0.0–5.5)) was
signiﬁcantly higher in the DSS group compared to the NC
Figure 5: Pedunculated adenocarcinoma with ﬁbrovascular stalk
and heads containing dysplastic epithelial glands in colonic mucosa
from a rat in the AOM group.
Figure 6: Colonic mucosa free from dysplastic foci in the area
between the polyps in the AOM group.
group (0.0 (0.0-0.0); P = 0.038) and AOM group (0.0 (0.0-
0.0); P = 0.04) (Figure 9). A total of 26 dysplastic lesions
distributed over 5 animals were found in the DSS group
compared to none in the other groups. The same pattern was
achieved for colonic ulcers, that is, 11 ulcers were found in
the DSS group (1.0 (0.5–2.5), while none were found in the
other two groups (P = 0.01 versus NC group; P = 0.014
versus AOM group) (Figure 10). The number of polyps in
the AOM group was in total 30, distributed over 3 animals.
In the DSS group, 3 polyps were found, distributed over 2
animals. No polyps were found in the NC group.
3.5. Translocation and Histopathological Evaluation of the
Liver. No signiﬁcant diﬀerence in the incidence of translo-
cation of live bacteria to the liver or to the mesenteric lymph
nodes was seen between groups (Table 3).
Livers of the NC group showed varying degree of
macrovesicularsteatosis(Figure 11).Mildsteatohepatitiswas
observed in one case within the steatotic areas. In the DSS
group, a mild-to-moderate degree of steatosis was found.
Liver lobules had occasional focal areas with parenchymal
loss, haemorrhage, and small inﬂammatory inﬁltrations in
nonsteatotic area (Figure 12). Only slight hepatic steatosis8 Gastroenterology Research and Practice
Figure 7: Ulceration, thickening of the mucosal wall, and a polyp
in distal colon from a rat in the DSS group.
Figure 8: Invagination as a cause of a polyp in colon of a rat in the
DSS group.
could be seen in specimens from the AOM group. In neither
case, parenchymal inﬂammatory inﬁltration, parenchymal
loss, or haemorrhage could be found (Figure 13).
By use of a numerical scoring system, the degree of
parenchymal inﬂammatory inﬁltration in nonsteatotic area
was shown to be signiﬁcantly higher in the DSS group (2.0
(2.0-2.0)) compared to the NC group (0.0 (0.0-0.0) P<
0.001) and AOM group (0.0 (0.0-0.0) P<0.001) (Table 3).
The incidence of parenchymal inﬂammatory inﬁltration was
also found to be signiﬁcantly higher in the DSS group (P<
0.001) as well as stasis (P<0.05) and a signiﬁcantly lower
incidence of steatosis in the AOM group compared to the
other groups (P<0.05) (Table 3).
3.6. Feacal Bacterial Counts. At the point in time corre-
sponding to the 7th day of DSS administration (ﬁrst DSS
cycle), the faecal count of Enterobacteriaceae increased,
reachinglevelsoflog8.6(8.4–8.9)CFU/g(AOM)(P<0.001)
and 7.4 (7.1–7.7)CFU/g (DSS) (P = 0.001), compared to
the base line. The diﬀerence of the Enterobacteriaceae count
between the AOM group and the DSS group was signiﬁcant
(P<0.001). At the last day of the study, the Enterobacteri-
aceae count was still higher in the DSS group compared to
base line (7.6 (7.5–7.8))CFU/g (P<0.001), but not in the
AOM group (6.5 (6.1–6.8)CFU/g. The load of Enterobacteri-
aceae in the DSS group wassigniﬁcantly higher thanboth the
NC group (P = 0.001) and the AOM group (P<0.001).
0
2
4
6
8
10
NC DSS AOM
N
u
m
b
e
r
o
f
d
y
s
p
l
a
s
t
i
c
l
e
s
i
o
n
s
∗ ∗
Figure 9: Number of dysplastic lesions in colon classiﬁed as low-
grade dysplasia in diﬀerent treatment groups. DSS 3.0 (0.0–5.5);
AOM 0.0; NC 0.0. ∗Denotes P<0.05 compared to the DSS group.
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Figure 10: Number of ulcers of colonic and rectal mucosa in
diﬀerent treatment groups. DSS 1.0 (0.5–2.5); AOM 0.0; NC 0.0.
∗∗Denotes P ≤ 0.01 and ∗denotes P<0.05 compared to the DSS
group.
After 7d of DSS treatment at the ﬁrst cycle, faecal
viable count of lactobacilli was higher in the AOM group
(11.2 (11.1–11.5))CFU/g than in the DSS group (10.0 (9.1–
10.3))CFU/g (P<0.001). The AOM group also showed
an increase compared to the start of the study (9.5 (9.1–
9.8))CFU/g (P<0.001). From the start to the end of
the study, only the NC group exhibited an increase in
lactobacilli count (start 10.0 (9.2–10.1)CFU/g; end 10.4
(10.2–10.8))CFU/g (P = 0.006), and, from faecal samples
collected at the last day of the study, the concentration was
higher in the NC group than in the other two groups (DSS,
9.1 (9.0–9.2)CFU/g; AOM, 9.2 (9.1–9.3)CFU/g, P<0.001).
3.7. Identiﬁcation of Faecal Lactobacilli and
Translocating Bacteria in the Liver
3.7.1. Faeces. Not all of the picked isolates from the Rogosa
plates could be identiﬁed. A total of 30 out of 44 picked
colonies were identiﬁed through RAPD band patternGastroenterology Research and Practice 9
Figure 11: Macrovesicular steatosis, involving most regions of the
hepatic lobule. The intracytoplasmic fat is seen as white vacuoles in
a rat of the NC group.
Figure 12: Focal areas with parenchymal loss and haemorrhage in
the liver from a rat of the DSS group.
Figure 13: Slightly hepatic steatosis in the liver of a rat in the AOM
group.
comparison and 16S rDNA sequencing. Obtained sequences
were at least 700 base-pair long, and the results showed
no less than 99% sequence similarity to their nearest
database entries. The majority of the recovered sequences
were identiﬁed to diﬀerent Lactobacillus spp., only a single
sequence was assigned to Biﬁdobacterium (Table 4).
In the NC group, B. animalis, L. reuteri, and L. murinus
were identiﬁed during the baseline period. At the point in
time corresponding to the 10th DSS cycle, L. murinus was
dominant. In the DSS group L. murinus dominated through
the whole study period. In the AOM group, L. reuteri and L.
intestinalis were found in the baseline samples. After the ﬁrst
and only DSS administration to the AOM group, L. reuteri
and L. gasseri were isolated, and, at termination, L. reuteri
and L. vaginalis were identiﬁed (Table 4).
3.7.2. Liver. Fifteen bacterial isolates from the liver were
subjected to 16S rDNA sequencing. Only, Lactobacillus ani-
malis was identiﬁed from livers in the NC group (Table 3). In
the DSS group, Kocuria rhizophila, Micrococcus luteus, Clo-
stridium ramosum,a n dStaphylococcus warneri were found
besides diﬀerent Lactobacillus spp., and, in livers from the
AOM group, only Clostridium perfringens and K. rhizophila
could be identiﬁed (Table 3).
3.8. SCFAs in the Hindgut. No diﬀerences in caecal pH were
found between the groups. The NC group had a higher
caecal level of butyric acid (26.7μmol/g) than the DSS group
(12.1μmol/g, P = 0.001) or AOM group (16.7μmol/g, P =
0.048). In the distal part of colon, the levels of acetic
and propionic acid in the DSS group (47.2μmol/g and
13.1μmol/g) were higher compared with the NC group
(31.7μmol/g and 8.9μmol/g) (P = 0.002 and P = 0.018,
resp.) (data not shown).
The proportion of acetic acid was higher, and that of
butyric acid was lower in the DSS group than in the NC
group (P = 0.007 and P<0.001, resp.) (Table 5). Similar
diﬀerences could also be found in the proximal (P = 0.007
and P = 0.018, resp.) and distal part of colon (P<0.001 and
P = 0.002, resp.). Furthermore, the proportion of butyric
acid in the proximal colon in the DSS group was lower than
that in the AOM group (P = 0.047). In the distal part of
colon in the AOM group, the acetic acid proportion was
higher than in the NC (P = 0.035) (Table 5).
3.9. SCFAs in Aortic Blood. Acetic acid was the main acid
in the aortic blood in all rats (94.3%), followed by butyric
acid (2.0%), i-valeric acid (1.5%), i-butyric acid (1.1%), and
propionic acid (1.0%) (data not shown).
The level of propionic acid was higher in the DSS
group (11.2μmol/L, P<0.001) than in the AOM group
(7.9μmol/L, P = 0.002), but both were lower than the
level in the NC group (15.4μmol/L, P = 0.039). The same
relationships were found when evaluating the proportions.
The AOM group had a lower proportion of propionic acid
(0.7%) compared with the NC group (1.3%, P = 0.022) or
DSS group (1.1%, P = 0.039).
3.10.BodyTemperature. Thebaselinetemperatureoftherats
was 37.4◦C (37.0–37.5) in the NC group, 36.8◦C (36.5–37.0)
intheDSSgroup,and37.2◦C(36.6–37.3)intheAOMgroup,
with a signiﬁcant diﬀerence found between the NC group
and the DSS group (P = 0.014). The temperaturevaried over
time,and,duringthecorrespondingpointintimeoftheﬁfth
DSS cycle, the temperature was again lower in the DSS group
(36.8◦C (36.2–37.3)) than in the AOM group (37.6◦C (37.3–
38.3)) (P = 0.014). At the end of the study (corresponding to
the tenth DSS cycle), the temperature reached similar values
in all three groups (NC, 37.6◦C (36.9–37.7)); DSS, 37.5◦C
(36.6–37.7); AOM, 37.5◦C (37.1–37.8).10 Gastroenterology Research and Practice
Table 4: Faecal ﬂora. Identiﬁcation of isolates from plate count of faeces from diﬀerent rat groups (L. = Lactobacillus and B. =
Biﬁdobacterium).
Group Base line
Time point
after DSS
cycle 1
Time point
after DSS
Cycle 10
Termination
NC
B. animalis
L. reuteri
L. murinus
L. murinus
L. murinus
L. murinus
DSS
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
L. murinus
AOM
L. reuteri
L. intestinalis
L. intestinalis
L. gasseri
L. reuteri
L. gasseri
L. vaginalis
L. vaginalis
L. vaginalis
L. reuteri
Table 5:Short-chainfattyacids.Distributionbetweenacetic,propionic,andbutyricacid(%)inthegutcontentofratsindiﬀerenttreatment
groups1,2.
Normal DSS AOM
Mean SEM Mean SEM Mean SEM
Caecum3
Acetic 55.1a 2.6 66.0b 1.4 62.1a,b 2.8
Propionic 14.4 0.6 16.9 1.1 14.7 0.8
Butyric 30.5a 2.4 17.1b 1.1 23.2a,b 2.7
Proximal3
Acetic 62.2a 1.8 69.5b 1.2 65.2a,b 1.5
Propionic 17.8 0.9 16.1 1.0 15.5 0.8
Butyric 20.0a 1.1 14.4b 1.4 19.4a 1.6
Distal4
Acetic 57.6a 1.5 66.4b 1.5 63.7b 1.4
Propionic 17.2 1.7 18.4 1.5 17.2 1.3
Butyric 25.2a 2.2 15.3b 1.6 19.1a,b 1.5
1Mean values with their standard errors of mean for 8 rats per group.
2Mean values with unlike superscript letters in the same line were signiﬁcantly diﬀerent (P<0.05).
3AOM, n = 7.
4AOM, n = 5.
3.11. Haptoglobin. The haptoglobin baseline value of the
DSS group (0.38mg/mL (0.26–0.55) was higher than for
the other groups (NC group, 0.17mg/mL (0.14–0.35); P =
0.043 compared with the DSS group, and AOM group,
0.17mg/mL (0.06–0.23); P = 0.006 compared with the DSS
group).OntheseventhdayofDSSadministration(1stcycle),
the haptoglobin level of the DSS group was signiﬁcantly
lower (P = 0.041) than for the AOM group (DSS group,
0.26mg/mL (0.23–0.38); AOM group, 0.49mg/mL (0.45–
0.49)). At the points in time corresponding to the 5th
through 10th DSS cycles, no diﬀerences were seen between
the groups. Over time (from start to the 10th DSS cycle),
the haptoglobin levels increased in all three groups, NC
0.73mg/mL (0.47–0.90) (P<0.001), DSS 0.75mg/mL
(0.51–0.98) (P = 0.029), and AOM 0.62mg/mL (0.57–0.65)
(P<0.001). At the point in time corresponding to the tenth
DSS cycle, a negative correlation was found between body
temperature and haptoglobin levels, where the temperature
tended to decrease while the values of haptoglobin increased
(r =− 0.50, P = 0.02).
3.12. Multiple Cytokine Assays. No diﬀerences between the
groups were found in terms of the cytokine proﬁle (data
not shown). In the end of the study, the level of leptin in
aortic blood was lower in the DSS group (3463.35 (2755.60–
4678.69)pg/mL) than in the NC group (7012.10 (4440.81–
8519.44pg/mL) (P = 0.04)) and the AOM group (5638.15
(4806.53–6588.72) (P = 0.038)).
4. Discussion
A procedure of repeated cyclic administration of 4% DSS
in the drinking water followed by periods without DSS
was used for inducing chronic inﬂammation, dysplasiaGastroenterology Research and Practice 11
and cancer and was compared to a model using AOM-
induced colonic carcinogenesis. DSS is not considered to
be mutagenic and responds negatively in the Ames test for
mutagens [29]. Consequently, the changes occurring in the
DSS group can presumably be attributed to the inﬂamma-
tion and regeneration of the colonic mucosa, recurrence-
remission cycles typical of clinical ulcerative colitis cases
[30]. In contrast, AOM is a genotoxic colon carcinogen,
in this case given once followed by a short exposure of
DSS for promotion of colitis-associated colon cancer. This
AOM model has been implicated to generate large bowel
adenocarcinomas in the short term, and their histology and
biological alteration resemble those found in humans [31].
However, usage of AOM alone induces polypoid tumours
with clinical, histological, and molecular features that mimic
h u m a ns p o r a d i cc o l o nc a n c e r[ 32].
DSS feeding for seven days resulted in a mild colitis in
both treatment groups, and this status continued during the
experimental period for some of the animals in the AOM
group. A gradually increased inﬂammatory activity was
recordedintheDSSgroup,indicatedbyasigniﬁcantincrease
in the disease activity index. The impaired recovery between
exposurestoDSSmaysuggestachronologicsequence,where
repeated uninhibited acute inﬂammatory responses develop
chronicity. The analysis of body weight gain across the
experimental period revealed a lower body weight gain for
both the DSS and AOM group.
MPO content is a marker of neutrophil inﬁltration at
the site of mucosal injury, and assessment of MPO activity
is considered a reproducible and qualitative estimate of
mucosal inﬂammation [33], so it may serve as a quanti-
tative index of disease severity. Analysis of colonic MPO
activity showed an elevation in the DSS group (Figure 1),
indicative of severe mucosal inﬂammation of descending
colon. MPO levels have also been found to be increased in
colorectal mucosa of patients with adenoma or carcinoma
[34].
The pathogenesis of colorectal carcinogenesis associated
with colonic inﬂammation is believed to involve progression
from inﬂamed and hyperplastic cryptal cells, through dys-
plasia,toadenomaandcarcinoma[35].Microscopicﬁndings
ofdescendingcolondemonstratedhistologicalabnormalities
with dysplasia and adenocarcinomas in both the DSS group
and the AOM group (Figures 3, 4,a n d5). However, the
incidence of low-grade dysplasia was signiﬁcantly elevated
by repeated administration of DSS (Table 2). This ﬁnding
corresponds with the frequency of appearance of the num-
ber of low-grade dysplasia (Figure 9) and mucosal ulcers
(Figure 10) found through macroscopic observation. By
using DSS and diﬀerent DAI scores, Cooper et al. [14]
were able to demonstrate that animals with dysplasia and/or
cancer have higher inﬂammatory scores. As precursors of
adenomas, dysplasia has been identiﬁed as a hallmark of
malignant potential [36]. Although not signiﬁcantly diﬀer-
ent, a high number of adenocarninomatous polyps with
severe dysplasia were found in the AOM group, distributed
in few animals. Obviously, animals from the same group at
thesametimepointsmayormaynotdevelopcarcinogenesis,
despite equivalent treatment. This diversity of diagnosis
could be explained by diﬀerences in host immune system
and individual genotype [37]. Strain diﬀerences in the
susceptibilitytobothAOMandDSShavebeenfoundinmice
[38], and it seems that Sprague-Dawley rats in their response
to AOM are more prone to individual animal variations than
during cyclic DSS treatment. Macroscopically, no distinct
signs of mucosal inﬂammatory reactions such as thickening
of the mucosal wall or gross mucosal ulceration were
observed in the AOM group. Mild mucosal redness or minor
ulcers might cause the slight rectal bleeding, found in a few
animals. Aside from the polyps, there were no dysplastic foci
in the mucosa in this group (Figure 6), probably because
inﬂammation was less intense or resolved more rapidly after
one cycle of DSS exposure.
There is a close relationship between UC and various
hepatobiliary disorders [10], and, during colonic cancer,
malignant tissue may disrupt the bowel architecture and
increase gut permeability [6]. Through the portal vein,
gut-derived components are easily accessible to the liver.
Increased translocation through the intestinal epithelium
during UC may allow bacterial antigens and toxins to cause
inﬂammatory reactions when reaching the liver [39]. In the
present study, inﬂammatory inﬁltrations in the parenchyma
were neither seen in the NC nor the AOM group but were
prominent in the DSS group (Table 3, Figures 11, 12,a n d
13). Moreover, the incidence of stasis was also elevated in
the DSS group (Table 3). The reason for the stasis seen in
liver specimens is unclear, but theoretically it could be due
to circulatory failure. We do not know if the DSS treatment
causes other damages, for instance to the heart or the kid-
n e y s .T h eo c c u r r e n c e so fs t e a t o t i ca r e a sw e r el e s sf r e q u e n t l y
found in the AOM than in the NC or DSS group (Figures
11, 12,a n d13, Table 3). Fatty inﬁltration of hepatocytes has
been reported during intestinal inﬂammation [40]; however,
the colonic mucosa was not inﬂamed in the NC group but
was in the DSS group. It seems as the inﬂamed condition in
the livers of the DSS group has proceeded past the stage of
steatosis.
Although no signiﬁcant diﬀerence in the incidence of
translocationwasfoundbetweengroupsinthepresentstudy,
no potential pathogenic bacteria were found in the livers of
the NC group (Table 3). Of the lactobacilli found, L. animalis
(phylogenetically related to L.murinus), L. frumenti and L.
antri (members of the L. reuteri subgroup) [41], and L.
gasseri are all normally found in rodents [42, 43]. Neither
S. warneri nor M. luteus is regarded as a dominating part
of the resident bacterial ﬂora of the gut, but S. warneri has
been isolated from the skin of laboratory mice [44], and
M. luteus has been shown to colonise the gastrointestinal
tract of rats after inoculation [45]. Both M. luteus and
K. rhizophila are able to cause infections in humans [46,
47]. In this study, the chronicity of the debilitating disease
and the accompanying inﬂammation may put the animals
at increased risk for opportunistic infections. C. ramosum
and C. perfringens were isolated from the DSS group and
the AOM group, respectively (Table 3). Diﬀerent species
of Clostridium have been implicated in the induction of
intestinal inﬂammation and may be detrimental when a
dysfunction of the colonic mucosal barrier is present [48].12 Gastroenterology Research and Practice
Okayasu et al. [30] showed increased number of diﬀerent
members of the families Enterobacteriaceae, Bacteroidaceae,
and Clostridiaceae during DSS-induced colitis, and increas-
ing numbers of B. distasonis and C. ramosum were partic-
ularly signiﬁcant after repeated administration. Enhanced
antibody response against C. ramosum,w h i c hw a so n eo f
the most frequently isolated anaerobes from the inﬂamed
mucosa of UC patients, has been demonstrated [49]. No
members of the family Bacteroidaceae were found in the
livers in the present study. Viable count of faeces revealed an
increase in Enterobacteriaceae after 11 administration cycles
of the alternating DSS-tap water regime when compared
with preadministration values for the DSS group only.
This value was also signiﬁcantly higher compared to the
other two groups. Faecal microbial communities in patients
with UC diﬀer from those in healthy individuals [7]. An
overrepresentation of Escherichia coli (belonging to the
familyEnterobacteriaceae)withhighmetabolicactivity,along
with lower numbers of lactobacilli has been seen [50, 51].
This is comparable to our results, which also showed a
decrease of lactobacilli in both the DSS and the AOM group
compared to the NC group.
Colonic microbial communities and SCFA fermentation
in patients with colonic disease might diﬀer from the ones
considered as normal. Signiﬁcantly higher proportions of
acetate and lower proportions of butyrate in enema samples
from patients with adenomatous polyps have been shown
[52]. These results suggest an increase in the ﬂoral capacity
to produce acetate and a decrease in the capacity to form
butyrate during colon cancer [52]. Furthermore, it has been
reported that the capacity of the faecal microbiota from
patients with colonic adenomas and colon cancer to produce
butyrate was signiﬁcantly reduced [53]. Another hypothesis
could invoke diﬀerences in the metabolism of SCFAs by the
colonocytes [52]. In the present study, signiﬁcantly higher
proportions of acetate and lower proportions of butyrate
in the content of caecum, proximal, and distal colon were
foundintheDSSgroupcomparedtotheNCgroup(Table 5).
Furthermore, as in the study of Weaver et al. [52], the
concentration of acetate and propionate were signiﬁcantly
higherindistalcolonoftheDSSgroup;thus,theresultsfrom
the analysis of luminal SCFAs indicate similarities between
the model of DSS-induced tumour development and the
clinical situation.
In aortic blood, the concentration of propionic acid was
higher in the DSS group compared to the AOM group, but
both were lower than the NC group. It has been speculated
whether a cirrhotic, dysfunctional liver is able to metabolise
SCFAs, leading to a rise in systemic concentrations [54].
Propionate serves as a substrate for gluconeogenesis [54],
and since the livers in the AOM group were the less aﬀected
and because this group also stated the lowest feed intake
and body weight gain, it may indicate a higher gluco-
neogenic rate due to starvation caused by occlusive colon
cancer.
Haptoglobin, an acute phase reactant, has been impli-
cated as a useful marker of inﬂammation in rats [55]a n d
is elevated during DSS administration [56]. After seven days
of DSS exposure in the ﬁrst and only DSS cycle of the
AOM group, a higher haptoglobin level was found in this
group than in the DSS group, probably as a result of the
higher concentration of DSS. At the end of the experimental
period, no diﬀerence was found between the three groups. It
might have been expected that the haptoglobin level in the
heavily inﬂamed DSS group would have been higher than
that of the NC group. On the other hand, the NC group had
fatteningtendencieswhichcanexplainasomewhatincreased
haptoglobin level, while it is well known that liver injury
resultsindecreasedhaptoglobinconcentrations[57,58],that
is, both inﬂammation due to colitis and due to fattening
tended to increase the haptoglobin level, and presumably to
the same degree in the present case.
In the serum, only very low levels of cytokines were
recorded (data not shown). The cytokine production proﬁle
for this model in rats has not been established, but chronic
colitis induced by DSS in mice displayed an enhanced
prohumoral cytokine bias [59], and so these results are
unexpected and have to be further elucidated.
Serum leptin is directly correlated with the body fat
stores,increasingwithfataccumulation[60],andthehighest
level was found in the NC group. Evidence has demonstrated
that the level of haptoglobin was increased in obese mice
[56], and since both leptin and haptoglobin were increased
in the NC, this might presumably indicate overweight
animals in this group, which also corresponds to the liver
steatosis. Most likely, there is a match between age, low
physical activity, and increased body weight. The lowest
level was found in the DSS group, which coincides with
ﬁndings from UC patients, suggesting that chronic intesti-
nal inﬂammation may decrease circulation leptin values
[61].
5. Conclusions
Chronic colitis associated with dysplasia has been found in
rats after DSS exposure [62]. In the present study, we were
able to develop low-grade as well as high-grade dysplasia
and colitis-associated cancer. As seen in UC patients [2],
development of dysplastic lesions seems to be related to the
duration and severity of the colonic inﬂammatory processes.
Our colitis model using repeated exposure to DSS needs a
longer treatment period to induce carcinogenesis, but the
AOM model appears to show dissociation between the sever-
ity of intestinal inﬂammation and development of cancer.
In this DSS model, we were also able to document altered
liver function by endogenous inﬂammatory mediators, as
well as fermentation patterns that closely mimic the clinical
situation, and so the model may be a valuable tool for
investigation of UC-related dysplasia and colon cancer.
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